Guidance on converting between anticoagulants
Transition of Anticoagulants 2016
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Updated Guidelines on Outpatient Anticoagulation | AAFP
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Transitioning Between Anticoagulants Continuous Infusion Unfractionated Heparin (UFH) SC LMWH or Fondaparinux Rivaroxaban (Xarel
Transition of Anticoagulants 2014
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
New Oral Anticoagulants: A Review - ppt video online download
Xarelto® - Responsible Use
Anticoagulants | Health Navigator NZ
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
